Tariq Musa 4

What Happened
Tariq Musa, a member of Guardant Health’s board of directors, reported derivative activity and the vesting/settlement of restricted stock units (RSUs) on June 17, 2026. The filing shows: 4,203 shares were exercised/converted (derivative M) and immediately disposed (reported as $0), and 2,711 shares were acquired as an RSU award (reported at $0). All transactions are reported at $0 per share, consistent with vesting/conversion and net settlement rather than an open‑market cash purchase or sale.

Key Details

• Transaction date: June 17, 2026; Form 4 filed June 22, 2026 (filed after the 2-business-day reporting window).
• Reported prices/consideration: $0.00 per share for all items (typical for RSU vesting / conversion entries).
• Shares acquired: 2,711 RSU shares delivered.
• Shares exercised/converted and disposed: 4,203 shares (likely used to satisfy tax withholding or settlement).
• Shares owned after transaction: not disclosed in the provided excerpt.
• Footnotes:
  • F1: The RSU award vested in full on the date of the 2026 Annual Meeting (June 17, 2026).
  • F2: Not applicable for RSUs.
  • F3: Notes a vesting provision (vests in full on one‑year anniversary of grant or next annual meeting, whichever earlier).

Context
This looks like routine equity compensation settlement: RSUs vested and a portion of shares were surrendered/converted (commonly to cover taxes or settlement obligations) while the remaining shares were delivered to the director. These entries are not open‑market purchases or discretionary sales and therefore should be interpreted as compensation-related, not a directional bet on the stock. The Form 4 was filed several days after the transaction date, exceeding the standard 2-business-day reporting deadline, which is a timeliness note for investors tracking insider activity.